These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 35853466)
1. Anal Botulinum Toxin in Children with Hirschsprung Disease and Functional Constipation: A Prospective Cohort study. Baaleman DF; Hallagan A; Halleran DR; Orsagh-Yentis DK; Levitt MA; Wood RJ; Benninga MA; Bali N; Vaz KH; Yacob D; Di Lorenzo C; Lu PL Eur J Pediatr Surg; 2023 Jun; 33(3):241-248. PubMed ID: 35853466 [TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin injection for internal anal sphincter achalasia after pull-through surgery in Hirschsprung disease. Youn JK; Han JW; Oh C; Kim SY; Jung SE; Kim HY Medicine (Baltimore); 2019 Nov; 98(45):e17855. PubMed ID: 31702647 [TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin is efficient to treat obstructive symptoms in children with Hirschsprung disease. Wester T; Granström AL Pediatr Surg Int; 2015 Mar; 31(3):255-9. PubMed ID: 25616563 [TBL] [Abstract][Full Text] [Related]
5. Transcutaneous needle-free injection of botulinum toxin: a novel treatment of childhood constipation and anal fissure. Keshtgar AS; Ward HC; Clayden GS J Pediatr Surg; 2009 Sep; 44(9):1791-8. PubMed ID: 19735827 [TBL] [Abstract][Full Text] [Related]
6. Intrasphincteric botulinum toxin injections for post-operative obstructive defecation problems in Hirschsprung disease: A retrospective observational study. Roorda D; Oosterlaan J; van Heurn E; Derikx J J Pediatr Surg; 2021 Aug; 56(8):1342-1348. PubMed ID: 33288128 [TBL] [Abstract][Full Text] [Related]
7. Preliminary experience with intrasphincteric botulinum toxin for persistent constipation after pull-through for Hirschsprung's disease. Langer JC; Birnbaum E J Pediatr Surg; 1997 Jul; 32(7):1059-61; discussion 1061-2. PubMed ID: 9247234 [TBL] [Abstract][Full Text] [Related]
8. A prospective study of botulinum toxin for internal anal sphincter hypertonicity in children with Hirschsprung's disease. Minkes RK; Langer JC J Pediatr Surg; 2000 Dec; 35(12):1733-6. PubMed ID: 11101725 [TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin injections after surgery for Hirschsprung disease: Systematic review and meta-analysis. Roorda D; Abeln ZA; Oosterlaan J; van Heurn LW; Derikx JP World J Gastroenterol; 2019 Jul; 25(25):3268-3280. PubMed ID: 31333317 [TBL] [Abstract][Full Text] [Related]
10. Transanal rectal mucosectomy and partial internal anal sphincterectomy for Hirschsprung's disease. Zhang JS; Li L; Hou WY; Liu SL; Diao M; Zhang J; Ming AX; Cheng W J Pediatr Surg; 2014 May; 49(5):831-4. PubMed ID: 24851780 [TBL] [Abstract][Full Text] [Related]
11. A comparative observational study on intrasphincteric injections with Botulinum toxin vs. enteral neuromodulation in chronic refractory constipation. Walther M; Müller H; Weiß C; Carbon R; Diez S; Besendörfer M BMC Pediatr; 2023 Sep; 23(1):448. PubMed ID: 37684559 [TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin injection for childhood constipation is safe and can be effective regardless of anal sphincter dynamics. Zar-Kessler C; Kuo B; Belkind-Gerson J J Pediatr Surg; 2018 Apr; 53(4):693-697. PubMed ID: 29395154 [TBL] [Abstract][Full Text] [Related]
13. Internal anal sphincter achalasia in children: clinical characteristics and treatment with Clostridium botulinum toxin. Ciamarra P; Nurko S; Barksdale E; Fishman S; Di Lorenzo C J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):315-9. PubMed ID: 12960655 [TBL] [Abstract][Full Text] [Related]
14. Can botulinum toxin help in managing children with functional constipation and obstructed defecation? Radwan AB; Gadallah MA; Shahawy MR; Albagdady AA; Talaat AA J Pediatr Surg; 2021 Apr; 56(4):750-753. PubMed ID: 32739102 [TBL] [Abstract][Full Text] [Related]
15. Outcome after anal intrasphincteric Botox injection in children with surgically treated Hirschsprung disease. Han-Geurts IJ; Hendrix VC; de Blaauw I; Wijnen MH; van Heurn EL J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):604-7. PubMed ID: 25000353 [TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin, a new treatment modality for chronic idiopathic constipation in children: long-term follow-up of a double-blind randomized trial. Keshtgar AS; Ward HC; Sanei A; Clayden GS J Pediatr Surg; 2007 Apr; 42(4):672-80. PubMed ID: 17448764 [TBL] [Abstract][Full Text] [Related]
17. Quality of life outcomes in children with Hirschsprung disease. Collins L; Collis B; Trajanovska M; Khanal R; Hutson JM; Teague WJ; King SK J Pediatr Surg; 2017 Dec; 52(12):2006-2010. PubMed ID: 28927976 [TBL] [Abstract][Full Text] [Related]
18. Bowel function and fecal continence after Soave's trans-anal endorectal pull-through for Hirschsprung's disease: a local experience. Zakaria OM Updates Surg; 2012 Jun; 64(2):113-8. PubMed ID: 22392576 [TBL] [Abstract][Full Text] [Related]
19. Functional outcomes in Hirschsprung disease: A single institution's 12-year experience. Thakkar HS; Bassett C; Hsu A; Manuele R; Kufeji D; Richards CA; Agrawal M; Keshtgar AS J Pediatr Surg; 2017 Feb; 52(2):277-280. PubMed ID: 27912977 [TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in children with Hirschsprung disease and children with functional constipation: Parent-child variability. Tham SW; Rollins MD; Reeder RW; Lewis KE; Calkins CM; Avansino JR; Palermo TM J Pediatr Surg; 2022 Aug; 57(8):1694-1700. PubMed ID: 35491270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]